## Can Genetic Testing Predict Non-Hodgkin’s Lymphoma Risk? Non-Hodgkin’s lymphoma (NHL) is a group of cancers that start in the lymphatic system, which is part of the body’s immune system. There are many types of NHL, and they can behave…
## Epstein-Barr Virus and Non-Hodgkin’s Lymphoma: A Deep Dive Epstein-Barr virus (EBV) is one of the most common human viruses, infecting nearly everyone at some point in their lives. While it often causes mild or no symptoms, EBV has a…
Non-Hodgkin’s lymphoma (NHL) is a broad category of cancers that originate in lymphocytes, which are a type of white blood cell crucial to the immune system. These cancers can develop in lymph nodes or lymphatic tissues in various organs such…
Studying environmental risk factors for non-Hodgkin’s lymphoma (NHL) is a complex and multifaceted process that involves a variety of research methods and disciplines. Researchers aim to understand how different environmental exposures might contribute to the development of this cancer. Here’s…
Diet and nutrition can significantly influence the outcomes of non-Hodgkin’s lymphoma (NHL) by supporting the immune system, managing treatment side effects, and potentially improving overall survival and quality of life. While diet alone cannot cure NHL, proper nutritional strategies can…
Non-Hodgkin’s lymphoma (NHL) is a diverse group of cancers that originate from the lymphocytes, which are a type of white blood cell crucial for the immune system. These cancers can be broadly categorized into two main types based on their…
Immunotherapy has emerged as a promising approach to improve the quality of life for patients with non-Hodgkin’s lymphoma (NHL), a diverse group of blood cancers affecting the lymphatic system. Unlike traditional treatments such as chemotherapy and radiation, which directly attack…
Stem cell transplantation plays a significant and evolving role in the research and treatment of non-Hodgkin’s lymphoma (NHL), a diverse group of blood cancers affecting the lymphatic system. This approach primarily involves two types of transplants: autologous stem cell transplantation…
Older adults can tolerate aggressive treatments for non-Hodgkin’s lymphoma (NHL), but their ability to do so depends on multiple factors including overall health, comorbidities, functional status, and the specific subtype and stage of NHL. Treatment decisions in older patients require…
Researchers study immune system dysfunction in non-Hodgkin’s lymphoma (NHL) through a variety of detailed and multifaceted approaches that combine clinical observations, laboratory experiments, and advanced molecular techniques. Their goal is to understand how the immune system is altered by the…